Kutki - NutraPedia
Back to Table of Contents
Kutki: An Overview of Its Uses and Implications
1. Conditions Studied for Kutki's Use
Kutki (Picrorhiza kurroa), a traditional Ayurvedic herb, has been studied for various health conditions, including:
- Liver disorders such as hepatitis and jaundice
- Immune system modulation
- Respiratory ailments like asthma
- Gastrointestinal issues
- Inflammatory diseases
- Antioxidant and antiviral properties
2. Efficacy in Treating Conditions
While traditional use suggests beneficial effects, scientific evidence on Kutki's efficacy is still emerging. Some studies have shown potential benefits in liver protection and immune response modulation, but these findings require further clinical trials to establish definitive efficacy.
3. Health Benefits of Kutki
- Protective liver effects: Kutki is known for its hepatoprotective properties that may assist in liver health and recovery.
- Immune system support: It might enhance immune function by modulating immune response.
- Anti-inflammatory: Contains compounds that could help reduce inflammation in the body.
- Respiratory health: May aid in mitigating symptoms of respiratory conditions.
- Antioxidant: The presence of antioxidants helps in combating oxidative stress.
4. Downsides of Kutki
Kutki is generally considered safe when used in appropriate doses. However, some potential downsides include:
- Possible side effects at high doses, such as gastrointestinal discomfort or allergic reactions.
- Risk of liver damage with excessive use, contrary to its hepatoprotective effects at lower doses.
- Insufficient data on its long-term safety profile.
5. Kutki: Genetic Considerations
There is limited research on the interaction between Kutki and specific genetic variations. However, individuals with genetic predispositions affecting liver metabolism or immune response might experience differing effects from Kutki. It is essential to consult healthcare professionals for personalized advice, especially when considering genetic factors.
Summary of Research on Kutki (Picrorhiza kurroa)
About Kutki (Picrorhiza kurroa)
Kutki, scientifically known as Picrorhiza kurroa, is a traditional herb used in Ayurvedic medicine. It is primarily used for liver disorders, respiratory issues, fever, dyspepsia, chronic diarrhea, and scorpion stings. It grows in the Himalayan region and is characterized by a bitter-tasting, creeping rootstock, flat oval leaves, and white or pale purple flowers. Concerns exist about its threatened status due to unregulated harvesting.
Pharmacokinetics and Active Compounds
Research into Kutki's pharmacokinetics focuses on the absorption, distribution, metabolism, and excretion of its two active compounds, picrosides I and II. Studies show differences in bioavailability depending on the form administered, with the extract leading to higher bioavailability than capsules or the kutkin mixture. A new analytical method was developed to measure the concentrations of picrosides in rat plasma, providing insights for clinical use.
Extraction Techniques and Biosynthesis
Scientists have developed a new technique to extract kutkin from P. kurroa roots with a high yield. Understanding the biosynthetic pathway of picrosides is crucial due to the plant's endangered status and has led to the identification of intermediate compounds like catalpol and aucubin.
Therapeutic Potential and Clinical Trials
Various research papers discuss Kutki's potential in treating liver diseases, Parkinson's disease, asthma, and ulcerative colitis through its liver-protective, antioxidant, and anti-inflammatory properties. Clinical trials have shown significant improvements in liver function for patients with acute viral hepatitis.
Comparative Studies and Pharmacokinetics
Comparative studies on different species of Picrorhiza plants reveal variations in the presence of active compounds and their antioxidant activities. Pharmacokinetic studies on rats help understand how different compounds like gentiopicroside and verproside are absorbed and distributed in the body.
Conclusion
Kutki (Picrorhiza kurroa), with its active compounds picrosides I and II, demonstrates a range of potential medicinal benefits, especially for liver-related issues. Research continues to explore its pharmacokinetics, extraction methods, therapeutic potential, and clinical applications.
References:
- Picrorhiza kurroa. Monograph
- Comparative pharmacokinetic profiles of picrosides I and II from kutkin, Picrorhiza kurroa extract and its formulation in rats
- TLC densitometric quantification of picrosides (picroside-I and picroside-II) in Picrorhiza kurroa and its substitute Picrorhiza scrophulariiflora and their antioxidant studies
- Structure of kutkin, the bitter glucoside of Picrorhiza kurroa Royle ex Benth
- A proposed biosynthetic pathway of picrosides linked through the detection of biochemical intermediates in the endangered medicinal herb Picrorhiza kurroa
- Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model
- Antiasthmatic effects of Picrorhiza kurroa: androsin prevents allergen- and PAF-induced bronchial obstruction in guinea pigs
- New cucurbitacin glycosides from Picrorhiza kurrooa
- Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent--experimental & clinical studies
- A Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in mice
- Long term effect of aflatoxin B(1) on lipid peroxidation in rat liver and kidney: effect of picroliv and silymarin
- Pharmacokinetics and tissue distribution of gentiopicroside following oral and intravenous administration in mice
- Pharmacokinetics of verproside after intravenous and oral administration in rats
- Determination of the plasma pharmacokinetic and tissue distributions of swertiamarin in rats by liquid chromatography with tandem mass spectrometry
- Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs
- Hypolipemic effect of water extracts of Picrorrhiza kurroa in high fat diet treated mouse
- Hypolipemic effect of water extracts of Picrorrhiza rhizoma in PX-407 induced hyperlipemic ICR mouse model with hepatoprotective effects: a prevention study
- Antidiabetic activity of standardized extract of Picrorhiza kurroa in rat model of NIDDM
- Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils
- Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease
- Spirulina maxima pretreatment partially protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
- Protective effects of Picrorhiza kurroa on cyclophosphamide-induced immunosuppression in mice
- New antiasthmatic drugs from traditional medicine?
- AKL1, a botanical mixture for the treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over study
- A double-blind clinical trial of Arogya-wardhani--an ayurvedic drug--in acute viral hepatitis
- Biochemical changes induced in liver and serum of aflatoxin B1-treated male wistar rats: preventive effect of picroliv
- Hepatocurative effect of picroliv and silymarin against aflatoxin B1 induced hepatotoxicity in rats
- Picroliv protects against aflatoxin B1 acute hepatotoxicity in rats
- Protective effect of picroliv, active constituent of Picrorhiza kurrooa, against oxytetracycline induced hepatic damage
- Prevention of carbon tetrachloride-induced hepatic injury in mice by Picrorhiza kurrooa
- Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice
- Picroliv affords protection against thioacetamide-induced hepatic damage in rats
- Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice
- Choleretic effect of picroliv, the hepatoprotective principle of Picrorhiza kurroa
- Effect of Picroliv on cadmium-induced hepatic and renal damage in the rat
- Therapeutic efficacy of Picroliv in chronic cadmium toxicity
- Picroliv preconditioning protects the rat liver against ischemia-reperfusion injury
- Picroliv protects against monocrotaline-induced hepatic damage in rats
- Protective effect of picroliv against hydrazine-induced hyperlipidemia and hepatic steatosis in rats
- Picroliv and its components kutkoside and picroside I protect liver against galactosamine-induced damage in rats
- Picroliv protects against alcohol-induced chronic hepatotoxicity in rats
- Protection against Amanita phalloides by the iridoid glycoside mixture of Picrorhiza kurroa (kutkin)
- Ex vivo and in vivo investigations of picroliv from Picrorhiza kurroa in an alcohol intoxication model in rats
- Anticholestatic effect of picroliv, active hepatoprotective principle of Picrorhiza kurrooa, against carbon tetrachloride induced cholestasis
- A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease
- Cytokines in inflammatory bowel disease
- Cytokine and anti-cytokine therapies for inflammatory bowel disease
- Amelioration of murine dextran sulfate sodium-induced colitis by nuclear factor-kappaB decoy oligonucleotides
- NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases
- Effect of Picroliv on cadmium induced testicular damage in rat
- Prevention of acute cadmium toxicity by Picroliv
- Picrorhiza kurroa, an ayurvedic herb, may potentiate photochemotherapy in vitiligo
Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!
Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!